Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by intheteethon Dec 20, 2018 1:56pm
248 Views
Post# 29141830

If you follow TD

If you follow TDadvice, you would have been buying 80% higher yet selling now. 

It means nothing. Thomest keeps increasing their stake and I don't believe they would be doing that if they saw a loss in the long run.

The thing that worries me is if they're planning to outright sell the whole company, at what price would that happen? Above 1$? Above 2?...

Bankrupcy won't happen, taking the company private maybe but really doubtful when you look at the share count market cap. 

All in all I think it's a good gamble and personally not selling a single share at this level. 
Bullboard Posts